A long-term follow-up study of patients with coronavirus (COVID-19) associated pneumonia
- Conditions
- COVID-19 pneumonia, COVID-19 (SARS-CoV-2 infection)Infections and Infestations
- Registration Number
- ISRCTN11265821
- Lead Sponsor
- Genentech, Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 300
1. Informed consent by any patient capable of giving consent, or, when the patient is not capable of giving consent, by their legal/authorized representative
2. Aged =18 years at the time of providing informed consent
3. Able to comply with the study procedures, in the investigator's judgment
4. Participated in any Genentech/Roche sponsored study or any supported Genentech/Roche independent investigator study for COVID-19 associated pneumonia (Note: Includes patients who completed or discontinued early from these studies)
1. Participation in an interventional study at the time of enrollment or plans to enroll in an interventional study during this study
2. Any serious medical condition or abnormality of clinical laboratory tests that, in the investigator’s judgment, precludes the patient’s safe participation in and completion of the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method